IBKS No3 SPAC (225430) - Total Assets
Based on the latest financial reports, IBKS No3 SPAC (225430) holds total assets worth ₩47.71 Billion KRW (≈ $32.33 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
IBKS No3 SPAC - Total Assets Trend (2015–2025)
This chart illustrates how IBKS No3 SPAC's total assets have evolved over time, based on quarterly financial data. Also see market value of IBKS No3 SPAC for the company's overall valuation and market capitalisation.
IBKS No3 SPAC - Asset Composition Analysis
Current Asset Composition (December 2025)
IBKS No3 SPAC's total assets of ₩47.71 Billion consist of 8.1% current assets and 91.9% non-current assets. Review IBKS No3 SPAC (225430) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0.8% |
| Accounts Receivable | ₩1.17 Billion | 2.5% |
| Inventory | ₩2.02 Billion | 4.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩20.21 Million | 0.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how IBKS No3 SPAC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See IBKS No3 SPAC stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IBKS No3 SPAC's current assets represent 8.1% of total assets in 2025, a decrease from 100.0% in 2015.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2025, down from 3.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 4.4% of total assets.
IBKS No3 SPAC Competitors by Total Assets
Key competitors of IBKS No3 SPAC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Senvest Capital Inc.
TO:SEC
|
Canada | CA$6.06 Billion |
|
Nuveen Multi-Asset Income Fund
NYSE:NMAI
|
USA | $691.82 Million |
|
Sprott Physical Silver
TO:PSLV
|
Canada | CA$9.40 Billion |
|
Janus Henderson Group PLC
F:HDJA
|
Germany | €8.29 Billion |
|
Compagnie du Cambodge
PA:CBDG
|
France | €6.94 Billion |
|
Fair Oaks Income Limited
LSE:FAIR
|
UK | $236.01 Million |
|
Central Securities Corporation
NYSE MKT:CET
|
USA | $1.79 Billion |
|
A.F.P. Habitat
SN:HABITAT
|
Chile | CL$772.89 Billion |
IBKS No3 SPAC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.28 | 0.41 | 1.56 |
| Quick Ratio | 0.14 | 0.15 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.56 |
| Working Capital | ₩-11.45 Billion | ₩-6.06 Billion | ₩4.01 Billion |
IBKS No3 SPAC - Advanced Valuation Insights
This section examines the relationship between IBKS No3 SPAC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.11 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -5.3% |
| Total Assets | ₩46.39 Billion |
| Market Capitalization | $2.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values IBKS No3 SPAC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: IBKS No3 SPAC's assets decreased by 5.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for IBKS No3 SPAC (2015–2025)
The table below shows the annual total assets of IBKS No3 SPAC from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩46.39 Billion ≈ $31.44 Million |
-5.27% |
| 2024-12-31 | ₩48.97 Billion ≈ $33.19 Million |
-3.13% |
| 2023-12-31 | ₩50.56 Billion ≈ $34.26 Million |
-1.42% |
| 2022-12-31 | ₩51.28 Billion ≈ $34.75 Million |
-2.65% |
| 2021-12-31 | ₩52.68 Billion ≈ $35.70 Million |
+4.85% |
| 2020-12-31 | ₩50.24 Billion ≈ $34.05 Million |
+16.45% |
| 2019-12-31 | ₩43.14 Billion ≈ $29.24 Million |
+31.79% |
| 2018-12-31 | ₩32.74 Billion ≈ $22.18 Million |
+228.46% |
| 2017-12-31 | ₩9.97 Billion ≈ $6.75 Million |
+0.49% |
| 2016-12-31 | ₩9.92 Billion ≈ $6.72 Million |
+0.42% |
| 2015-12-31 | ₩9.88 Billion ≈ $6.69 Million |
-- |
About IBKS No3 SPAC
KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more